Aly, Zeinab Aly Moussa http://orcid.org/0000-0003-2100-0993
El Gharib, Mohamed
Hetta, Waleed M. http://orcid.org/0000-0002-2453-7449
Soliman, Khaled Sayed
Article History
Received: 6 February 2022
Accepted: 28 March 2022
First Online: 4 April 2022
Declarations
:
: The study was approved by the Research Ethical and Scientific Committee of Faculty of Medicine at Ain Shams University in Egypt 'The committee’s reference number of approval: FWA 000017585.' Patients’ privacy and their data confidentiality were guaranteed with a restricted access to the patients’ data except for the principal investigator. Written informed consents to participate in the study were obtained from all patients or their legal guardians. The patients were informed of the prostatic hyperplasia current management lines, a detailed explanation of the procedure and possible intervention-related complications: contrast-induced allergic reactions, nephropathy, epididymo-orchitis, accidental arterial puncture, arteriovenous fistula, puncture site hematoma, venous dissection, post embolization pain, non-target embolization, and possible technical failure.
: A consent for publication was obtained for the data of each individual included in the study, given by the patients themselves or their legal guardians.
: The authors declare that there are no competing interests.